休 LIGHT는 자연법칙을 존중하는 기반에서 몸속 명의(名醫)들이
그 역할을 잘 할 수 있도록 지원하는 일을 해 나가겠습니다.
Whole-body Photobiomodulation (PBM) Treatment Device
Whole-body PBM chamber is registered as a medical device by the KFDA and USFDA.
Korean medical
device manufacturing
quality certification
ISO 13485
Medical
Devices
USA Medical
Devices
510k exempted
- Photobiomodulation (PBM) is a medical term that summarizes the process of activating blood, lymphatic circulation, nerve cells, ATP, and NO in the human body by a specific light source.
- This keyword was registered in December 2016 as a major keyword for future therapeutic methods in the MeSH (Medical Subject Headings) of the National Institutes of Health in the United States.
- Only products designed and manufactured according to the principles of photobiology (1,2) can be called Photobiomodulation (PBM).
Photobiomodulation (PBM) Working Mechanism
The pinnacle of functional medicine = Whole-body PBM Medicine
July 2021, Faculty of Medicine, University of Sydney
Results: Treatment with PBM for 12 weeks to up to a year significantly improved measures of mobility, cognition, dynamic balance, and fine motor skills. PBM has shown to be a safe and potentially effective treatment for various clinical signs and symptoms of PD. In the case of neurodegenerative diseases where a decline is generally expected, improvement was maintained for up to a year as long as the treatment continued.
April 2020, PBM University Research Institute, Germany
Data Extraction Method
In the initial systematic search of the database, 354 papers related to PD were identified, out of which 28 studies met the inclusion criteria (Figure 1). 22 papers reported on rodent experiments, and 5 papers reported studies on primates (Macaque monkeys, Macaca fascicularis).
Results: PBM therapy could be an effective treatment for Parkinson's disease (PD) in human patients. PBMT of the brain prevents neuronal degeneration. This systematic review addresses reports describing the use of PBM to treat experimental animal models of PD, with the aim of deriving conclusions on the best parameter selection and investigative techniques. Clinical trials of PBM in patients have already been reported and more are expected in the future. PBM is particularly attractive as it is a non-pharmacological treatment with minimal side effects (almost no minor side effects)
Worldwide implementation of PBM therapy devices
November 2020, Centre de Haute Energie, Nice, France – a 50-year-old cancer treatment specialty hospital
City of Hope Comprehensive Cancer Center, Duarte CA, USA – a California-based cancer treatment specialty hospital
Data Extraction Method
As of April 2020, a total of 67 studies related to PBMT and cancer were identified: 43 in vitro, 15 in vivo, and 9 confirmed clinical studies met the inclusion criteria.
Results: PBMT appears to be safe and successful in managing cancer treatment-related side effects. Therefore, PBMT should be considered as part of the standard care for certain oncological purposes. Clinicians should be able to prescribe PBM according to guideline recommendations using appropriately approved PBMT parameters in the clinical setting. The safety of PBM with respect to tumor response and most importantly, the benefits of PBM to patients in managing cancer treatment-related toxicity were demonstrated in in vivo studies and clinical trials
August 2022, Faculty of Medicine and Life Sciences, University of Hasselt, Diepenbeek, Belgium
Source: This paper is based on the recommendations of the 12th WALT (World Association of photobiomoduLation Therapy) conference held in Nice from October 3-6, 2018, a follow-up review of existing data, and clinical observations of an international, interdisciplinary panel of clinicians and researchers with expertise in the field.
This report reviews the potential preventive and therapeutic effects of photobiomodulation (PBM) on the side effects of cancer treatments, including chemotherapy (CT), radiation therapy (RT), and hematopoietic stem cell transplantation (HSCT).
Conclusion
As recently outlined by the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO), there is substantial evidence demonstrating the efficacy of PBM in preventing oral mucositis (OM) in specific cancer patient groups.
There is strong evidence for the use of PBM therapy to prevent and treat a wide range of complications in cancer treatment. Specific clinical practice guidelines or evidence-based expert consensus recommendations are provided
Example of how Korean Cancer Specializing Nursing Hospital utilized whole-body PBM Therapy using our device
November 2019, Clinical Research at the Faculty of Medicine, University of Norway
PBM Therapy Before High-Intensity Running Test in Soccer Players: Functional, Muscular Damage, Inflammation and Oxidative Stress Markers - A Randomized Controlled Trial
Convenient Function
Standards and Specification
Whole body PBM Treatment Machine
(Invention Patent)
Light source with a specific wavelength range
38,800 chips for three-dimensional close-proximity irradiation to the human body
Customizable functions for different conditions (Frequency modulation and pulsing features)
Selection of 7-stage pulse signals (Nogier Frequency)
Control operation method
External control and smartphone app Total POWER
Total POWER
4,000W
Treatment time
20 minutes per session
HUE LIGHT CO., LTD SK Techno park E-1311. 60, Haan-ro, Gwangmyeong-si, Gyeonggi-do, Republic of KoreaE-MAIL: info@huelight.krTEL : 02-898-2116
Copyright 2018 Dynatech. All Rights Reserved.
Disclaimer : The medical papers and academic information provided on this site are intended for educational purposes only and are not meant to diagnose, treat, prevent diseases, or substitute for a doctor's advice.
